CUA 2018 Kidney Cancer

Viewing 1-14 of 14 articles

CUA 2018: Outcomes of Metastasectomy in Metastatic Renal Cell Carcinoma Patients: The Canadian Kidney Cancer Information System Experience

CUA 2018: Development of a Patient Decision Aid for Complex, Localized Renal Masses

CUA 2018: Surveillance Post-Radio Frequency Ablation For Small Renal Masses: Recurrence and Follow-Up

CUA 2018: Comparative Survival Following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma

CUA 2018: Surveillance Post-Radio Frequency Ablation for Small Renal Masses: Recurrence and Follow-Up

CUA 2018: Predictors of a Positive Genetic Test Result in Patients with a Suspected Hereditary Kidney Cancer Syndrome: Results from a Provincial Medical Genetics Unit

CUA 2018: Development of a Patient Decision Aid for Complex, Localized Renal Masses

CUA 2018: Renal Cell Carcinoma in the Canadian Indigenous Population

CUA 2018: Comparing Outcomes of Second Line Axitinib or Everolimus in Metastatic Renal Cell Carcinoma Patients: Results From the Canadian Kidney Cancer Information System

CUA 2018: Comparing Laparoscopic Cytoreductive Nephrectomy to Open Surgery: A Large, Multicentre, Retrospective Analysis

CUA 2018: Identifying the Spatio-Functional Origins of Drug Resistance with Rapid Tumour Xenografts

CUA 2018: Cytoreductive Nephrectomy in the Era of TKI Systemic Therapy

CUA 2018: 1st and 2nd Line Therapy in Kidney Cancer: Practice Changing Trials

CUA 2018: Role of Cytoreductive Nephrectomy in 2018